Influenza in the Asia-Pacific region: Findings and recommendations from the Global Influenza Initiative |
| |
| Institution: | 1. School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region;2. NIVEL, Dutch Institute for Health Services Research, Utrecht, The Netherlands;3. Queen Sirikit National Institute of Child Health, Ministry of Public Health, Bangkok, Thailand;4. University of Indonesia, Jakarta Pusat, Indonesia;5. University of the Philippines Manila, College of Medicine, Philippine General Hospital, Manila City, Philippines;6. Institute of Environmental Science and Research (ESR), Wallaceville, Upper Hutt, New Zealand;7. Sher-i-Kashmir Institute of Medical Sciences, Srinagar, India;8. National Taiwan University Children''s Hospital, Taipei, Taiwan;9. Institute of Respiratory Medicine, Kuala Lumpur, Malaysia;10. University of Pennsylvania, Doylestown, PA, USA;1. Institute of Infectious Diseases and Endemic Diseases Control, Beijing Center for Disease Prevention and Control, Beijing, China;2. School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region;3. Division of Infectious Disease, Key Laboratory of Surveillance and Early-Warning on Infectious Disease, Chinese Center for Disease Control and Prevention, Beijing, China;4. Foundation for the Promotion of Health and Biomedical Research in the Valencia Region FISABIO – Public Health, Valencia, Spain;5. School of Public Health and Community Medicine, The University of New South Wales, Sydney, NSW 2052, Australia;6. School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China;1. Department of Anthropology, Northwestern University, Evanston, IL 60208, United States;2. Cells to Society (C2S): The Center on Social Disparities and Health, Institute for Policy Research, Northwestern University, Evanston, IL 60208, United States;3. Office of Population Studies Foundation and Department of Nutrition and Dietetics, University of San Carlos, Cebu City, Philippines;4. Carolina Population Center and Department of Nutrition, University of North Carolina, Chapel Hill, NC, United States;1. GSK, Wavre, Belgium;2. icddr,b, Dhaka, Bangladesh;3. American University of Beirut, Beirut, Lebanon;4. GSK, King of Prussia, PA, USA;5. GSK, Rockville, MD, USA;6. Khon Kaen University, Khon Kaen, Thailand;7. National Autonomous University of Santo Domingo, Santo Domingo, Dominican Republic;8. Dr Castroviejo Primary Health Care Center, Madrid, Spain;9. Complutense University of Madrid, Madrid, Spain;10. Jaume I University and Illes Columbretes Health Center of Castellón, Castellón de la Plana, Spain;11. Tecnologia en Investigacion, San Pedro Sula, Honduras;12. National Autonomous University of Honduras, Tegucigalpa, Honduras;13. FISABIO-Public Health, Valencia, Spain;14. Eskisehir Osmangazi University, Eskisehir, Turkey;15. University of Southampton, Southampton, UK;p. University Hospital Southampton NHS Foundation Trust, Southampton, UK;q. Hospital Infantil Universitario La Paz, Madrid, Spain;r. Mary Chiles General Hospital, Manila, Philippines;s. University of the Philippines—Philippine General Hospital, Manila, Philippines;t. Royal Manchester Children''s Hospital, Manchester, UK;u. Center of Postgraduate Medical Education, Warsaw, Poland;v. Centre for Community Medicine, All India institute of Medical Sciences, New Delhi, India;w. Research Institute for Tropical Medicine, Manila, Philippines;x. Paediatric Institute Mares-Riera, Blanes, Spain;y. Hospital Clínico Universitario de Santiago, Santiago, Spain;z. Hospital of Antequera, Malaga, Spain;11. EAP Sardenya-IIB Sant Pau, Barcelona, Spain;12. University of Hradec Kralove, Hradec Kralove, Czech Republic;13. Chulalongkorn University, Bangkok, Thailand;14. Medicentrum 6 s.r.o., Prague, Czech Republic;15. Nicolaus Copernicus University in Torun, Collegium Medicum, Bydgoszcz, Poland;16. University Hospital No 2, Bydgoszcz, Poland;17. Instituto Hispalense de Pediatría, Sevilla, Spain;18. Catholic University of Louvain, Cliniques Universitaires St Luc, Brussels, Belgium;19. GSK, Bangalore, India;110. St Hedwig of Silesia Hospital, Trzebnica, Poland;111. EBA Centelles, Barcelona, Spain;1. Vadu Rural Health Program, King Edward Memorial Hospital Research Center, Pune, India;2. Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India;3. Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, USA;4. National Institute of Virology, Indian Council of Medical Research, 20-A, Dr Ambedkar Road, Pune 411001, India;5. INCLEN Trust International, New Delhi, India;6. National Institute of Mental Health and Allied Sciences, Bangalore, India;1. National Institute of Hygiene and Epidemiology, Viet Nam;2. Epidemic Intelligence Service, Centers for Disease Control and Prevention, USA;3. Influenza Division, Centers for Disease Control and Prevention, USA;4. Pasteur Institute, Ho Chi Minh City, Viet Nam;5. Pasteur Institute, Nha Trang, Viet Nam;6. Pasteur Institute, Tay Nguyen, Viet Nam |
| |
| Abstract: | The fourth roundtable meeting of the Global Influenza Initiative (GII) was held in Hong Kong, China, in July 2015. An objective of this meeting was to gain a broader understanding of the epidemiology, surveillance, vaccination policies and programs, and obstacles to vaccination of influenza in the Asia-Pacific region through presentations of data from Australia, Hong Kong, India, Indonesia, Malaysia, New Zealand, the Philippines, Taiwan, Thailand, and Vietnam.As well as a need for improved levels of surveillance in some areas, a range of factors were identified that act as barriers to vaccination in some countries, including differences in climate and geography, logistical challenges, funding, lack of vaccine awareness and education, safety concerns, perceived lack of vaccine effectiveness, and lack of inclusion in national guidelines. From the presentations at the meeting, the GII discussed a number of recommendations for easing the burden of influenza and overcoming the current challenges in the Asia-Pacific region. These recommendations encompass the need to improve surveillance and availability of epidemiological data; the development and publication of national guidelines, where not currently available and/or that are in line with those proposed by the World Health Organization; the requirement for optimal timing of vaccination programs according to local or country-specific epidemiology; and calls for advocacy and government support of vaccination programs in order to improve availability and uptake and coverage.In conclusion, in addition to the varied epidemiology of seasonal influenza across this diverse region, there are a number of logistical and resourcing issues that present a challenge to the development of optimally effective vaccination strategies and that need to be overcome to improve access to and uptake of seasonal influenza vaccines. The GII has developed a number of recommendations to address these challenges and improve the control of influenza. |
| |
| Keywords: | Influenza Vaccination Surveillance Epidemiology Asia-Pacific |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
